MRT vs CHCT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 06, 2026

MRT

38.0
AI Score
VS
CHCT Wins

CHCT

58.9
AI Score

Investment Advisor Scores

MRT

38score
Recommendation
SELL

CHCT

59score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MRT CHCT Winner
Revenue 39.24M 121.19M CHCT
Net Income -41.45M 5.10M CHCT
Net Margin -105.6% 4.2% CHCT
ROE 61.8% 1.2% MRT
ROA -139.1% 0.5% CHCT
Total Assets 29.80M 990.76M CHCT
Cash 7.81M 3.34M MRT
Debt/Equity -1.28 1.24 MRT

Relative Price Performance (Last 90 Days)

MRT 1M: +12.8% · 3M: +12.2% CHCT 1M: -3.7% · 3M: -14.2%

Current Technical Phase

MRT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.0% over 20 days), RSI 50

RSI (14): 50.3 · Price: $2.02

CHCT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.9%), weak momentum, RSI 38

RSI (14): 37.8 · Price: $15.00

Fundamentals Snapshot

Metric MRT CHCT
Market Cap
Forward P/E 89.8 50.3
Trailing P/E 22.2
Revenue (TTM)
Revenue Growth 1.4% 0.1%
Gross Margin 0.7% 0.8%
Operating Margin 0.0% 0.3%
EPS -0.50 0.67
Dividend Yield 0.12%

Frequently Asked Questions

Based on our detailed analysis, CHCT is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.